PL2467128T3 - Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego - Google Patents

Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego

Info

Publication number
PL2467128T3
PL2467128T3 PL11748571.4T PL11748571T PL2467128T3 PL 2467128 T3 PL2467128 T3 PL 2467128T3 PL 11748571 T PL11748571 T PL 11748571T PL 2467128 T3 PL2467128 T3 PL 2467128T3
Authority
PL
Poland
Prior art keywords
glyceryl trinitrate
treating traumatic
traumatic edema
edema
treating
Prior art date
Application number
PL11748571.4T
Other languages
English (en)
Inventor
Marianne Boskamp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2467128T3 publication Critical patent/PL2467128T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL11748571.4T 2010-08-03 2011-08-03 Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego PL2467128T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102010033182 2010-08-03

Publications (1)

Publication Number Publication Date
PL2467128T3 true PL2467128T3 (pl) 2016-10-31

Family

ID=44509174

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11748571.4T PL2467128T3 (pl) 2010-08-03 2011-08-03 Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego

Country Status (7)

Country Link
US (3) US9180109B2 (pl)
EP (3) EP2467128B1 (pl)
AU (1) AU2011287948B2 (pl)
CA (1) CA2806636C (pl)
ES (1) ES2582309T3 (pl)
PL (1) PL2467128T3 (pl)
WO (2) WO2012016691A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2467128T3 (pl) * 2010-08-03 2016-10-31 Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego
ES2617494T3 (es) 2012-05-31 2017-06-19 G. Pohl-Boskamp Gmbh & Co. Kg Inducción de arteriogénesis con un donador de óxido nítrico tal como nitroglicerina
AT513312A1 (de) * 2012-08-17 2014-03-15 Gebro Holding Gmbh Antiseptische Zusammensetzung
HK1216546A1 (zh) * 2013-05-28 2016-11-18 Biogen Ma Inc. 评估pml风险的方法
AU2015235905B2 (en) 2014-03-28 2016-10-27 S.C. Johnson & Son, Inc. Pump concentrated air freshener
GB2592376A (en) * 2020-02-25 2021-09-01 Aer Beatha Ltd Canister

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (pl) * 1962-05-24
GB1205019A (en) 1966-12-07 1970-09-09 Sterwin Ag Improvements in or relating to oral dosage forms
JPS599539B2 (ja) 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
CA1163195A (en) 1980-06-26 1984-03-06 Alec D. Keith Polymeric diffusion matrix containing a vasodilator
US4542013A (en) 1981-07-08 1985-09-17 Key Pharmaceuticals, Inc. Trinitroglycerol sustained release vehicles and preparation therefrom
DE3246081A1 (de) 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
CA1319099C (en) * 1987-01-23 1993-06-15 James A. Nathanson Atriopeptins, guanylate cyclase activators, and phosphodiesterase inhibitors as treatment for glaucoma, hydrocephalus and cerebral edema (cranial fluid volume dysfunction)
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
HU199678B (en) 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
DE4007705C1 (pl) 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
DE4018919C2 (de) 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray
US5370862A (en) 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
DE4026072A1 (de) 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray
DE4038203A1 (de) 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen
US5698589A (en) 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
US5869082A (en) 1996-04-12 1999-02-09 Flemington Pharmaceutical Corp. Buccal, non-polar spray for nitroglycerin
US20010044584A1 (en) 1997-08-28 2001-11-22 Kensey Kenneth R. In vivo delivery methods and compositions
US20030095925A1 (en) 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
ATE209911T1 (de) 1997-10-03 2001-12-15 Warner Lambert Co Gepresste nitroglycerintablette und verfahren zu ihrer herstellung
US6796966B2 (en) 1997-10-15 2004-09-28 Jeffrey E. Thomas Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
WO1999038472A2 (en) 1998-01-28 1999-08-05 Seatrace Pharmaceuticals Inc Topical vasodilatory gel composition and methods of use and production
US5989529A (en) * 1998-11-20 1999-11-23 Schering-Plough Healthcare Products, Inc. Substantive topical composition
IT1303793B1 (it) 1998-11-27 2001-02-23 Promefarm S R L "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
RU2174838C2 (ru) * 1999-11-04 2001-10-20 Ивановская государственная медицинская академия Способ лечения тяжелого бронхообструктивного синдрома у детей раннего возраста
AU2727701A (en) 1999-12-15 2001-06-25 Cellegy Pharmaceuticals, Inc. Nitroglycerin ointment for treatment of pain associated with anal disease
US6443307B1 (en) 2000-01-25 2002-09-03 Michael D. Burridge Medication dispenser with an internal ejector
WO2001068062A2 (en) 2000-03-14 2001-09-20 Noven Pharmaceuticals, Inc. Packaging materials for transdermal drug delivery systems
US6538033B2 (en) 2000-08-29 2003-03-25 Huntington Medical Research Institutes Nitric oxide donor compounds
HUP0400264A2 (hu) 2001-06-22 2004-08-30 Pfizer Products Inc. Alacsony oldékonyságú és/vagy savra érzékeny hatóanyagokat és semlegesített savas polimereket tartalmazó gyógyszerkészítmények és eljárás az előállításukra
EP1480895B1 (en) 2002-02-08 2006-11-02 The Procter & Gamble Company Child resistant sachet
US20050095278A1 (en) 2003-01-14 2005-05-05 Viorel Nicolaescu Use of nitroglycerin to relieve nocturnal muscle cramps
US20040228883A1 (en) 2003-02-21 2004-11-18 Mitchell Karl Prepackaged aqueous pharmaceutical formulation for the treatment of cardiac conditions containing at least two different active agents and method of formulation
CA2530843A1 (en) 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US20070053966A1 (en) * 2003-10-17 2007-03-08 Robert Ang Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
US7781226B2 (en) 2004-02-27 2010-08-24 The Board Of Regents Of The University Of Texas System Particle on membrane assay system
JP2007526316A (ja) 2004-03-01 2007-09-13 ルーメン セラピューティックス リミテッド ライアビリティ カンパニー 疾患を処置するための組成物および方法
WO2005107461A2 (en) 2004-04-07 2005-11-17 The General Hospital Corporation Modulating lymphatic function
US20090221540A1 (en) 2006-01-09 2009-09-03 Pantarhei Bioscience B.V. Method of Treating An Acute Vascular Disorder
JP2009534387A (ja) 2006-04-19 2009-09-24 ノヴァデル ファーマ インコーポレイテッド 安定な含水アルコール性経口噴霧調剤物および方法
US20080193385A1 (en) * 2007-02-08 2008-08-14 Todd Maibach Compositions and methods for treating neuropathy
JP2010519336A (ja) 2007-02-26 2010-06-03 ルンドベルク，ヨン 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
CN101229148A (zh) 2007-12-28 2008-07-30 天津医科大学 硝酸甘油口腔(舌下)崩解片的制剂及其制备方法
DE102008005484A1 (de) 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
SI2098249T1 (sl) 2008-03-05 2013-02-28 Rivopharm Sa Nosilci nikorandila s povečano stabilnostjo
US20100184870A1 (en) 2008-03-14 2010-07-22 Rolf Groteluschen Long-term stable pharmaceutical preparation containing the active ingredient glycerol trinitrate
DE202008007318U1 (de) * 2008-03-14 2008-07-31 G. Pohl-Boskamp Gmbh & Co. Kg Langzeitstabile pharmazeutische Zubereitung mit dem Wirkstoff Glyceroltrinitrat
EP2379070A4 (en) * 2008-07-21 2013-11-13 Imi Internat Medical Innovations D B A Procris Pharmaceuticals WATER BASED TOPICAL STABLE PHARMACEUTICAL CREAMES AND METHODS FOR PREPARING AND USING SAME
JP2011010865A (ja) * 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
PL2467128T3 (pl) * 2010-08-03 2016-10-31 Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego

Also Published As

Publication number Publication date
ES2582309T3 (es) 2016-09-12
EP2990032A1 (en) 2016-03-02
EP2467128B1 (en) 2016-04-13
AU2011287948A1 (en) 2013-02-07
WO2012016691A1 (en) 2012-02-09
EP2467128A1 (en) 2012-06-27
US20130121930A1 (en) 2013-05-16
CA2806636A1 (en) 2012-02-09
US20160213637A1 (en) 2016-07-28
AU2011287948B2 (en) 2014-11-06
EP2600837A1 (en) 2013-06-12
CA2806636C (en) 2018-01-23
US9180109B2 (en) 2015-11-10
US20130129638A1 (en) 2013-05-23
US9693983B2 (en) 2017-07-04
WO2012016690A1 (en) 2012-02-09

Similar Documents

Publication Publication Date Title
ZA201304280B (en) Treatment of jak2-mediated conditions
SMT201900619T1 (it) Uso di pufa per la cura di un'infiammazione cutanea
ZA201301601B (en) Treatment of diseases
IL233111A0 (en) Preparations for the treatment of inflammation
SG10201508495VA (en) Combination treatment of cancer
GB201000916D0 (en) Treatment of biofilms
ZA201208413B (en) Skin treatment composition
IL228430A0 (en) Cancer treatment
ZA201308459B (en) A topical formulation for treatment of hyperkeratotic skin
HUE038787T2 (hu) Tripeptid készítmények és alkalmazásuk diabétesz kezelésére
IL225896A0 (en) Treatment of mecp-2 related disorders
EP2709665A4 (en) TREATMENT OF PSORIASIS
PL2467128T3 (pl) Zastosowanie triazotanu glicerolu do leczenia obrzęku urazowego
ZA201208389B (en) Treatment of proliferative diseases
EP2624835A4 (en) COMPOSITIONS FOR TREATING SCORIASIS OF SCALP
ZA201208568B (en) Skin treatment composition
GB201114289D0 (en) Flurbiprofen and related compounds for the treatment of skin diseases
GB201012926D0 (en) Compounds for treatment of inflammation
GB201107467D0 (en) Novel treatment of pain
LT2460509T (lt) Kompozicija, skirta karpų gydymui
GB201010638D0 (en) Composition for treatment of skin
GB201010671D0 (en) Compounds for treatment of inflammation
GB201005495D0 (en) Compounds for treatment of inflammation
GB201100651D0 (en) Treatment of inflammation
GB201009194D0 (en) Treatment of pain